Molecular Imaging of Invasive Pulmonary Aspergillosis Using ImmunoPET/MRI: The Future Looks Bright
Open Access
- 9 April 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 9, 691
- https://doi.org/10.3389/fmicb.2018.00691
Abstract
Invasive pulmonary aspergillosis (IPA) is a life-threatening lung disease of immuno-compromised humans caused by the ubiquitous environmental mould Aspergillus. Biomarker tests for the disease lack sensitivity and specificity, and culture of the fungus from invasive lung biopsy is slow, insensitive, and undesirable in critically ill patients. A Computed Tomogram (CT) of the chest offers a simple non-intrusive diagnostic procedure for rapid decision-making, and so is used in many haematology units to drive antifungal treatment. However, radiological indicators that raise the suspicion of IPA are either transient signs in the early stages of the disease, or are not specific for Aspergillus infection, with other angio-invasive moulds or bacterial pathogens producing comparable radiological manifestations in a chest CT. Improvements to the specificity of radiographic imaging of IPA have been attempted by coupling CT and Positron Emission Tomography (PET) with [18F]FDG, a marker of metabolic activity well-suited to cancer imaging, but with limited use in invasive fungal disease diagnostics due to its inability to differentiate between infectious etiologies, cancer, and inflammation. Bioluminescence imaging using single genetically modified strains of Aspergillus fumigatus has enabled in vivo monitoring of IPA in animal models of disease. For in vivo detection of Aspergillus lung infections in humans, radiolabelled Aspergillus-specific monoclonal antibodies, and iron siderophores, hold enormous potential for clinical diagnosis. This review examines the different experimental technologies used to image IPA, and recent advances in state-of-the-art molecular imaging of IPA using antibody-guided Positron Emission Tomography/Magnetic Resonance Imaging (immunoPET/MRI).Funding Information
- Seventh Framework Programme (602820)
This publication has 96 references indexed in Scilit:
- Evaluation of Real-Time PCR, Galactomannan Enzyme-Linked Immunosorbent Assay (ELISA), and a Novel Lateral-Flow Device for Diagnosis of Invasive AspergillosisJournal of Clinical Microbiology, 2013
- In vitro and in vivo evaluation of selected 68Ga-siderophores for infection imagingNuclear Medicine and Biology, 2012
- Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- PET/MRI in infectious and inflammatory diseases: will it be a useful improvement?European Journal of Nuclear Medicine and Molecular Imaging, 2012
- The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised HostsClinical Infectious Diseases, 2011
- In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosisBMC Microbiology, 2010
- Tracking the Emerging Human Pathogen Pseudallescheria boydii by Using Highly Specific Monoclonal AntibodiesClinical and Vaccine Immunology, 2009
- BioluminescentAspergillus fumigatus, a New Tool for Drug Efficiency Testing and In Vivo Monitoring of Invasive AspergillosisApplied and Environmental Microbiology, 2008
- Development of an Immunochromatographic Lateral-Flow Device for Rapid Serodiagnosis of Invasive AspergillosisClinical and Vaccine Immunology, 2008
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008